This program is studying a compound designed to block the function of neutrophil elastase. Neutrophil elastase is a type of protein associated with inflammation in the lungs. Blocking the function of neutrophil elastase may minimise tissue destruction and decrease inflammation within the CF airway.
Phase 1 studies to test the safety of this compound are underway in Europe.
This program is sponsored by Polyphor and partially funded by Cystic Fibrosis Foundation Therapeutics (CFFT).
Contact us about POL6014 >